Clinical Trial Update: A Study for HSK47388 in Participants With Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating HSK47388 for ulcerative colitis is currently recruiting, sponsored by Haisco Pharmaceutical Group Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• HSK47388

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Ulcerative Colitis (UC) | Phase 2 | Status: RECRUITING